Glycemic control and excess mortality in type 1 diabetes

New England Journal of Medicine

Volumn 372, Issue 9, 2015, Pages 879-881

  Tornese, Gianluca ^a   Tubaro, Martina ^b   Ventura, Alessandro ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN;

CARDIOVASCULAR DISEASE; GLYCEMIC CONTROL; HAZARD RATIO; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LETTER; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; FEMALE; MALE; METABOLISM;

DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE;

EID: 84923789350     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1415677     Document Type: Letter

References (4)

1. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014;371: 1972-82.
2. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32-5.
3. Marcovecchio ML, Woodside J, Jones T, et al. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 2014;37:805-13.
4. Schmieder RE, Schrader J, Zidek W, et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007;96:247-57.